WallStSmart

Salesforce.com Inc (CRM)vsNice Ltd ADR (NICE)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 1331% more annual revenue ($43.94B vs $3.07B). CRM leads profitability with a 22.0% profit margin vs 13.9%. CRM appears more attractively valued with a PEG of 0.78. CRM earns a higher WallStSmart Score of 73/100 (B).

CRM

Strong Buy

73

out of 100

Grade: B

Growth: 7.3Profit: 8.0Value: 8.0Quality: 4.5
Piotroski: 5/9Altman Z: 1.50

NICE

Buy

58

out of 100

Grade: C

Growth: 5.3Profit: 6.0Value: 8.7Quality: 7.5
Piotroski: 4/9Altman Z: 3.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRMUndervalued (+65.3%)

Margin of Safety

+65.3%

Fair Value

$713.65

Current Price

$240.89

$472.76 discount

UndervaluedFair: $713.65Overvalued
NICEUndervalued (+33.8%)

Margin of Safety

+33.8%

Fair Value

$167.71

Current Price

$118.09

$49.62 discount

UndervaluedFair: $167.71Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRM6 strengths · Avg: 8.8/10
EPS GrowthGrowth
118.9%10/10

Earnings expanding 118.9% YoY

Market CapQuality
$198.10B9/10

Large-cap with strong market position

Return on EquityProfitability
25.2%9/10

Every $100 of equity generates 25 in profit

Profit MarginProfitability
22.0%9/10

Keeps 22 of every $100 in revenue as profit

PEG RatioValuation
0.788/10

Growing faster than its price suggests

Operating MarginProfitability
21.4%8/10

Strong operational efficiency at 21.4%

NICE4 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.9510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.798/10

Growing faster than its price suggests

P/E RatioValuation
16.3x8/10

Attractively priced relative to earnings

Areas to Watch

CRM2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

Debt/EquityHealth
1.093/10

Elevated debt levels

NICE2 concerns · Avg: 2.0/10
Price/BookValuation
45.9x2/10

Trading at 45.9x book value

EPS GrowthGrowth
-52.7%2/10

Earnings declined 52.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : CRM

The strongest argument for CRM centers on EPS Growth, Market Cap, Return on Equity. Profitability is solid with margins at 22.0% and operating margin at 21.4%. Revenue growth of 10.8% demonstrates continued momentum.

Bull Case : NICE

The strongest argument for NICE centers on Debt/Equity, Altman Z-Score, PEG Ratio. PEG of 0.79 suggests the stock is reasonably priced for its growth.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score, Debt/Equity.

Bear Case : NICE

The primary concerns for NICE are Price/Book, EPS Growth.

Key Dynamics to Monitor

CRM profiles as a mature stock while NICE is a value play — different risk/reward profiles.

CRM carries more volatility with a beta of 1.26 — expect wider price swings.

CRM is growing revenue faster at 10.8% — sustainability is the question.

CRM generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

CRM scores higher overall (73/100 vs 58/100), backed by strong 22.0% margins and 10.8% revenue growth. NICE offers better value entry with a 33.8% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Nice Ltd ADR

TECHNOLOGY · SOFTWARE - APPLICATION · USA

NICE Ltd. provides business software solutions globally. The company is headquartered in Ra'anana, Israel.

Visit Website →

Want to dig deeper into these stocks?